Showing results (761-770 of 830) with videos related to

Sort By:
Pageof 83
Plos Biology|September 28, 2020
High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studiesHabtamu B Beyene, Gavriel Olshansky, Adam Alexander T Smith, et al.
The Lancet. Diabetes & Endocrinology|December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trialFrederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
JAMA|April 3, 2022
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) LevelsSteven E Nissen, Kathy Wolski, Craig Balog, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 4, 2024
Unexpected gaps in knowledge of familial hypercholesterolaemia among Dutch general practitionersShirin Ibrahim, Jim N de Goeij, Nick S Nurmohamed, et al.
Nature Medicine|August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohortsGerald F Watts, Christian Schwabe, Russell Scott, et al.
BMJ Open|October 28, 2017
An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study"Jing Pang, Miao Hu, Jie Lin, et al.
Heart, Lung & Circulation|October 21, 2023
Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in AustraliaMitchell N Sarkies, Luke Testa, Stephanie Best, et al.
NEJM Evidence|February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in HypertriglyceridemiaDaniel Gaudet, Peter Clifton, David Sullivan, et al.
Journal of the American Heart Association|November 6, 2023
Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the CETP GeneChenglong Yu, Andrew Bakshi, Gerald F Watts, et al.
Nature Communications|October 7, 2023
Metabolic phenotyping of BMI to characterize cardiometabolic risk: evidence from large population-based cohortsHabtamu B Beyene, Corey Giles, Kevin Huynh, et al.
Pageof 83